Controlled Release Drug Delivery Market to Grow with a CAGR of 10.70% through 2028
Increasing Prevalence of Chronic Diseases and Advancements
in Drug Delivery Technology is expected to drive the Global Controlled Release
Drug Delivery Market growth in the forecast period, 2024-2028.
According to
TechSci Research report, “Controlled Release Drug Delivery Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2028”,
the Global Controlled Release Drug Delivery Market stood at USD 49.48 billion
in 2022 and is anticipated to grow with a CAGR of 10.70% in the forecast
period, 2024-2028. The awareness among individuals regarding Controlled Release
Drug Delivery has led to favorable market conditions for the global Controlled
Release Drug Delivery market. Several factors contribute to the growth of
various Controlled Release Drug Delivery products.
The global
increase in chronic diseases, such as diabetes, cardiovascular ailments,
cancer, and respiratory disorders, is largely attributable to factors like
sedentary lifestyles, unhealthy dietary habits, and a growing elderly
population. These chronic conditions often necessitate long-term medication,
making controlled release drug delivery systems an increasingly attractive
option. Controlled release systems provide a more effective and efficient
approach to administering medications for chronic diseases by ensuring a
consistent therapeutic drug level in the patient's bloodstream. This can result
in enhanced treatment outcomes and more effective management of these
illnesses.
Many older
individuals often find themselves managing multiple medications simultaneously,
which can be a challenging task. Controlled release formulations play a crucial
role in simplifying medication regimens by decreasing the frequency of dosing,
enhancing adherence, and mitigating the potential for medication errors. As
individuals age, their bodies may become more susceptible to the effects of
medications. Controlled release systems offer the advantage of gradual drug
release, thereby lowering the likelihood of adverse effects linked to sudden or
high doses, which will further fuel market growth.
In September
2023 - Johnson & Johnson Announces U.S. FDA Approval of AKEEGA™ (Niraparib
and Abiraterone Acetate) for the Treatment of Patients with BRCA-Positive
Metastatic Castration-Resistant Prostate Cancer.
In August 2023,
Alkermes Announces FDA Clearance of Investigational New Drug (IND) Application
for ALKS 8700, its Investigational Medicine for the Treatment of Agitation in
Patients with Schizophrenia.
Pharmaceutical
companies are increasingly focusing on drug development tailored to the
specific needs of the elderly population. Controlled release formulations are a
vital component of this approach, as they can improve drug efficacy and safety
in this demographic.
In today's
fast-paced world, individuals often have busy schedules and limited time for
healthcare management. Controlled release drug delivery systems simplify
medication regimens by reducing the frequency of doses. Patients can take their
medication less often, making it more convenient and less disruptive to their
daily routines. A fast-paced lifestyle can lead to forgetfulness or
difficulties in adhering to complex medication schedules. Controlled release
systems enhance medication adherence by offering a more straightforward dosing
regimen. Patients are more likely to stick to their treatment plans when they
have fewer doses to remember. Immediate-release medications may require
multiple doses throughout the day, causing disruptions at work or during
activities. Controlled release formulations reduce these disruptions by
providing a sustained therapeutic effect, allowing individuals to focus on
their tasks without constant interruptions. Chronic diseases like diabetes,
hypertension, and cardiovascular conditions require ongoing medication. Controlled
release drug delivery systems are particularly beneficial in managing these
conditions as they offer a steady release of medication, ensuring that patients
receive consistent treatment even in a fast-paced environment. The fast-paced
lifestyle can be stressful, and stress can affect how the body responds to
medications. Controlled release systems release drugs gradually, reducing the
risk of sudden peaks in drug levels that can lead to side effects or safety
concerns. In our fast-paced world, precision medicine is gaining importance.
Controlled release systems can be customized to deliver medications precisely
when and where they are needed in the body. This aligns with the trend toward
personalized healthcare and optimized treatment outcomes.
Patient convenience
and adherence are particularly important in the elderly and pediatric
populations, where medication management can be challenging. Controlled release
systems are especially beneficial in these groups, improving the likelihood
that patients receive the full therapeutic benefits of their medications.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Controlled Release Drug Delivery Market.”
In recent times,
medication adherence has become a critical concern. People often lead busy
lives, which can make it challenging to follow complex dosing schedules.
Controlled release systems simplify treatment by reducing the frequency of
doses. Patients are more likely to adhere to their medication plans when they
have a less demanding regimen. The modern world is characterized by fast-paced
lifestyles and hectic schedules. Controlled release drug delivery systems
provide convenience by minimizing the need for frequent medication
administration. Patients can manage their health more efficiently, even amidst
their busy routines. The prevalence of chronic diseases, such as diabetes,
hypertension, and cardiovascular conditions, is on the rise. Controlled release
systems are particularly useful in managing these long-term health conditions.
They ensure a steady release of medication, maintaining stable therapeutic
levels over extended periods. However, the Regulatory Hurdles and Approval
Delays may hinder market growth. Moreover, challenges related to High Research
and Development Costs and Physician and Patient Education may pose obstacles to
the Controlled Release Drug Delivery market in the near future.
The Global Controlled
Release Drug Delivery Market is segmented into technology, release mechanism, application,
regional distribution, and company.
Based on its Technology,
the Targeted drug delivery systems are designed to deliver medications directly
to specific sites or cells within the body, with pinpoint accuracy. This
precision minimizes drug exposure to non-target tissues, reducing the risk of
side effects and enhancing the therapeutic effect. It is particularly crucial
for the treatment of complex diseases like cancer, where minimizing damage to
healthy tissues is critical. Targeted delivery systems ensure that drugs reach
their intended targets at the right concentration and for the required
duration. This enhances therapeutic efficacy, as the drug is delivered
precisely where it is needed. In oncology, for example, targeted drug delivery
can improve tumor response rates while minimizing systemic toxicity. By
limiting drug exposure to healthy tissues, targeted delivery systems
significantly reduce the occurrence of adverse effects commonly associated with
traditional drug administration methods. Patients experience fewer side
effects, leading to improved treatment tolerance and adherence. The Targeted
Delivery category aligns with the trend toward personalized medicine. It
enables the customization of drug therapies based on an individual's unique
genetic makeup, disease characteristics, and response to treatment.
Based on region,
North America segment is expected to grow during the forecast period. North
America, including the United States and Canada, boasts highly advanced
healthcare infrastructure, including research facilities, pharmaceutical
companies, and a robust regulatory environment. This fosters the development,
approval, and adoption of controlled release drug delivery technologies. North
America faces a significant burden of chronic diseases such as diabetes,
cardiovascular disorders, and cancer. Controlled release drug delivery systems
are particularly effective in managing chronic conditions, driving their demand
in the region. The United States is a global leader in pharmaceutical research
and development. Many pharmaceutical companies based in North America are
actively investing in controlled release drug delivery technologies to offer
improved treatment options. The high healthcare spending in North America,
driven by both public and private investments, provides a conducive environment
for the adoption of advanced drug delivery systems. The FDA in the United
States has well-defined regulatory pathways for the approval of controlled
release drug delivery systems, making it easier for companies to bring
innovative products to market.
The Asia-Pacific
market is poised to be the fastest-growing market, offering lucrative growth opportunities
for Controlled Release Drug Delivery players during the forecast period.
Factors such as Many countries in the Asia-Pacific region, including China and
India, are increasing their healthcare expenditure to address the healthcare
needs of their growing populations. This translates to greater investment in
healthcare technologies, including controlled release drug delivery systems.
The Asia-Pacific region is home to a substantial and growing patient
population. The prevalence of chronic diseases is on the rise, driving the
demand for effective drug delivery solutions. Rapid economic growth in
countries like China and India has led to an expanding middle class with
increased healthcare awareness and affordability. This demographic shift
supports the adoption of advanced healthcare technologies. Many governments in
the Asia-Pacific region are actively promoting the development and adoption of
innovative healthcare solutions.
Major companies
operating in Global Controlled Release Drug Delivery Market are:
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Capsugel Inc
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The Advancements
in Drug Formulation and increasing chronic disease are key drivers of the Controlled
Release Drug Delivery and supplement market. In recent years, the growing Controlled
release systems help maintain steady drug levels in the bloodstream, reducing
side effects and enhancing drug efficacy. This drives their adoption for
critical therapeutic areas. Moreover, the growing consumer emphasis on
preventative healthcare products has enhanced production and marketing efforts.
To meet the demands of the market, manufacturers are increasingly incorporating
cutting-edge technologies with high production efficiency. Rising consumer
acceptance and continuous product innovation will further ensure the growth of
the Controlled Release Drug Delivery and supplements market in the coming
years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Controlled
Release Drug Delivery Market – Global Industry Size, Share, Trends,
Opportunity, & Forecast 2018-2028 Segmented By Technology (Wurster
Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted
Delivery, Others), By Release Mechanism (Polymer Based Systems, Micro Reservoir
Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery
Systems, Activation-modulated Drug Delivery Systems, Chemically Activated), By
Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches,
Infusion Pumps, Oral Controlled-drug delivery Systems, Drug Eluting Stents), By
Region, Competition”, has evaluated the future growth potential of Global
Controlled Release Drug Delivery Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Controlled Release Drug Delivery Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com